Add like
Add dislike
Add to saved papers

Research on the Role of Surface Treatment of the Metal Surface on the Strength of the Metal-Ceramic Bond.

AIM: The aim of the present study is to investigate the metal-ceramic bond strength as a result of three different surface treatment methods: (1) oxidation, (2) oxidation and sandblasting, and (3) double oxidation on the metal substrate.

MATERIALS AND METHODS: A total of 72 metal substrates were made from two different types of metal-ceramic alloys ( n = 36): group I, Ni-Cr and group II, Co-Cr alloys. Each group was further divided and subjected to three different surface treatments ( n = 12): (1) oxidation in accordance with the manufacturer's instructions; (2) oxidation according to the manufacturer's instructions and then sandblasting with Al2O3, with a grain size of 110 μm, a pressure of 75 psi for 10 sec with a distance of 5 cm and steam cleaning; and (3) double oxidation. The bond strength of the specimens was evaluated with the three-point bending process. The data were recorded, tabulated, and statistically analyzed.

RESULTS: For group I, the materials with oxidation based on the specifications, show mean value of 64.02 Nt. The oxidation and sandblasting materials have mean 55.92 Nt. The double oxidation materials have mean 55.47. For group II, the materials with oxidation based on the specifications, show mean value of 58.46 Nt. The oxidation and sandblasting materials have a mean value of 42.56 Nt. The double oxidation materials have mean 42.96 Nt.

CONCLUSION: The best method of treatment of the metal substrate is specification oxidation, in terms of the strength of the metal-ceramic bond. Further treatment of the metal substrate reduces the strength of the metal-ceramic bond.

CLINICAL SIGNIFICANCE: A prerequisite for clinical success of metal-ceramic prosthetic restorations is the increased strength of the bond between ceramic material and metal substrate. With that in mind, the present research gives important insight into best practices for prosthetic restorations.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app